1. Andrade R. and Nicoll R. A. (1985) The novel anxiolytic buspirone elicits a small hyperpolarisation and reduces serotonin responses at putative 5-HT1 receptors on hippocampal CA1 pyramidal cells. Soc. Neurosci. Abstr. 11, 597.
2. Cliffe I. A. (1993) The design of selective 5-HT1A receptor antagonists. 206th A.C.S. Meeting, Medi. Abstr. 30.
3. Cliffe I. A., Bill S. J., Dover G. M., Fletcher A., Forster E. A., Ifill A. D., Mansell H. L., Pitt W., Reilly Y. and White A. C. (1995) A series of potent and selective 5-HT1A receptor antagonists related to WAY-100135: Syntheses, SAR, and modelling studies. 209th A.C.S. Meeting Medi. Abstr. 59.
4. (S)-N-tert-Butyl-3- (4-(2-methoxyphenyl)piperazin-1-yl)-2-phenylpropanamide (S)-WAY100135;Cliffe;J. Med. Chem.,1993
5. Advances in 5-HT1A antagonist research;Cliffe;Drugs Fut,1993